B HALL STRATEGIES, LLC

Lobbying for TIBER CREEK GROUP ON BEHALF OF DAIICHI SANKYO, INC. · Global pharmaceutical company.

Filing Registration

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · posted Jul 15, 2025

Lobbying activity 1

Health Issues

Issues related to drug pricing and reimbursement for prescription drugs; Issues related to orphan drugs.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.